loadpatents
name:-0.015272855758667
name:-0.012094020843506
name:-0.00051307678222656
Tietje; Karin R. Patent Filings

Tietje; Karin R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tietje; Karin R..The latest application filed is for "diazabicyclic central nervous system active agents".

Company Profile
0.11.12
  • Tietje; Karin R. - Mundelein IL
  • Tietje; Karin R. - Philipsburg CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Diazabicyclic Central Nervous System Active Agents
App 20120208820 - Schrimpf; Michael R. ;   et al.
2012-08-16
Diazabicyclic central nervous system active agents
Grant 8,119,635 - Schrimpf , et al. February 21, 2
2012-02-21
Substituted diazabicycloalkane derivatives having affinity for nicotinic acetylcholine receptors
Grant 7,872,010 - Frost , et al. January 18, 2
2011-01-18
Diazabicyclic Central Nervous System Active Agents
App 20100016277 - Schrimpf; Michael R. ;   et al.
2010-01-21
Diazabicyclic central nervous system active agents
Grant 7,598,236 - Schrimpf , et al. October 6, 2
2009-10-06
Indoles are cannabinoid receptor ligands
Grant 7,560,481 - Frost , et al. July 14, 2
2009-07-14
Novel Indoles Are Cannabinoid Receptor Ligands
App 20090149501 - Frost; Jennifer M. ;   et al.
2009-06-11
Substituted Diazabicycloalkane Derivates
App 20080275048 - Frost; Jennifer M. ;   et al.
2008-11-06
Substituted diazabicycloalkane derivatives
Grant 7,399,765 - Bunnelle , et al. July 15, 2
2008-07-15
Diazabicyclic Central Nervous System Active Agents
App 20080097094 - Schrimpf; Michael R. ;   et al.
2008-04-24
Diazabicyclic central nervous system active agents
Grant 7,319,106 - Schrimpf , et al. January 15, 2
2008-01-15
Novel indoles are cannabinoid receptor ligands
App 20070037801 - Frost; Jennifer M. ;   et al.
2007-02-15
Azabicyclic compounds are central nervous system active agents
App 20060287290 - Dart; Michael J. ;   et al.
2006-12-21
Azabicyclic compounds are central nervous system active agents
Grant 7,135,484 - Dart , et al. November 14, 2
2006-11-14
Substituted diazabicycloalkane derivatives
App 20050101602 - Basha, Anwer ;   et al.
2005-05-12
Substituted diazabicycloakane derivatives
App 20050065178 - Basha, Anwer ;   et al.
2005-03-24
Diazabicyclic central nervous system active agents
Grant 6,809,105 - Schrimpf , et al. October 26, 2
2004-10-26
Diazabicyclic central nervous system active agents
App 20040186107 - Schrimpf, Michael R. ;   et al.
2004-09-23
Azabicyclic compounds are central nervous system active agents
App 20040152724 - Dart, Michael J. ;   et al.
2004-08-05
Diazabicyclic central nervous system active agents
App 20020019388 - Schrimpf, Michael R. ;   et al.
2002-02-14
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
Grant 5,597,823 - Meyer , et al. January 28, 1
1997-01-28
Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
Grant 5,288,749 - Meyer , et al. February 22, 1
1994-02-22
Adenosine-5'-carboxamides and method of use
Grant 4,167,565 - Stein , et al. September 11, 1
1979-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed